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Abstract
Background: Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI
fatality compared with the general population. In a previous study examining post-MI treatment in RA compared
with controls we noted that a higher proportion of the RA patients had experienced MI following a surgical procedure.
The aim of this study was to compare the risk of MI and mortality at 6 weeks and 12 months following joint surgery in
patients with RA compared with the general population.
Methods: Individuals who had undergone joint surgery in Victoria, Australia between 1 July 2000 and 30 June 2007
were identified from routinely collected hospital administrative data. Logistic regression analysis was performed to
examine odds of 6 week and 12 month MI and mortality in RA versus non-RA patients with adjustment for age, sex,
comorbidities, socioeconomic status, patient type and admission type. Subgroup analysis of total hip and knee
arthroplasty episodes was undertaken.
Results: A total of 308,589 episodes of joint surgery occurred among 240,571 individuals, with 3654 (1.2 %)
occurring among patients with RA. At 6 weeks post joint surgery the adjusted odds ratio (OR) for MI was 1.50
(95 % CI 0.96–2.33), all-cause death was 1.85 (95 % CI 1.09–3.13) and cardiovascular death was 1.90 (95 % CI 1.07–3.37).
At 12 months post joint surgery the adjusted OR of MI was 1.70 (95 % CI 1.27–2.28), all-cause death was 2.18 (95 % CI
1.66–2.86) and cardiovascular death was 2.30 (95 % CI 1.65–3.22). On analysis of joint surgeries other than hip or knee
arthroplasty, people with RA were at greater risk of MI within 6 weeks (adjusted OR 2.32; 95 % CI 1.24–4.34) and
12 months (adjusted OR 2.20; 95 % CI 1.47–3.30) compared to those without RA, but no difference in odds of
short term mortality were found.
Conclusions: Following an episode of joint surgery RA patients have a significantly increased risk of death at
6 weeks, and MI and death at 12 months, compared to the general population. The reasons for this remain to be
elucidated but in the meantime RA patients should be considered at higher risk in the perioperative period.
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Background
Rheumatoid arthritis (RA) is the most common form of
inflammatory arthritis affecting up to 1.3 % of people
worldwide and approximately 2 % of Australians [1, 2].
RA is associated with excess cardiovascular mortality and
morbidity, which contributes significantly to the burden of
this disease [3–5].
In an earlier study investigating mortality following a
first acute cardiovascular event we found RA patients
had increased 30-day case fatality after acute myocardial
infarction (MI) compared to the general population [4].
Subsequent interrogation of hospital data from three
Victorian tertiary referral centres showed that in patients
who experienced MI, a preceding medical illness or sur-
gical event was more substantially common among pa-
tients with RA than in those without RA (31 % vs 16 %,
respectively) [6]. In other words, in almost a third of the
RA patients who had MI, the MI had been preceded and
possibly precipitated by a medical or a surgical insult.
This led us to postulate that patients with RA might have
an increased burden of silent cardiovascular disease, which
is uncovered by a period of physiologic stress. To examine
this further we wished to measure the risk of MI and other
adverse cardiovascular outcomes in patients with RA com-
pared to the general population following some form of
physiologic insult. We chose joint surgery to represent our
physiologic insult given that is a relatively standardized
procedure that is not uncommonly performed in patients
with RA.
Hence, the primary aim of this retrospective cohort
study was to compare the risk of MI and death within
6 weeks and 12 months of any form of joint surgery in
patients with RA versus patients without RA. The limited
research into perioperative cardiovascular risk among
patients with RA is primarily based on examination of
cardiovascular complications following total knee joint
replacement (TKJR) and total hip joint replacement (THJR),
so we additionally performed subgroup analyses in these
groups to facilitate direct comparison [7–10].
Methods
Data sources
In the Australian state of Victoria, data pertaining to all
hospital admissions are collected within the Victorian
Admitted Episodes Dataset (VAED), which is maintained
by the Victorian Department of Health and Human
Services. This dataset contains demographic and clinical
information on each hospital admission, with the clinical
information coded in the format of the International
Statistical Classification of Diseases and Related Health
Problems, Tenth Revision, Australian Modification (ICD-
10-AM) [11]. Coding is based on review of the entire
record of the hospital admission, carried out by experi-
enced coders who obtain clinician input in the event of
uncertainty. Up to 40 clinical codes and 40 procedural
codes can be recorded for each hospital admission. The
Victorian Department of Health maintains VAED data
quality with an annual independent audit cycle, which
samples nearly 1 % of public hospital discharges [12].
The Victorian Death Index is maintained by the Victorian
Registry of Births, Deaths and Marriages and is a record of
all certified deaths. Since 1 July 1996, statistical linkage
techniques have been used to match records from the
VAED to the Death Index. The linked data formed the
basis of our study.
Study population and definitions
All admissions with a procedure code indicating joint
surgery (see Additional file 1) between 1 July 2000 and
30 June 2007 were included in the primary analysis. Sub-
group analysis of THJR, TKJR episodes and all other joint
surgeries was also undertaken. Data for at least 2 years
prior to, and 12 months following, the joint surgery
admission were available to identify patients with RA
(with a 2-year retrospective period) and end points of
interest as outlined below. As such, the total dataset
spanned the period 1 July 1998 to 30 June 2008. Indi-
viduals with RA were identified by the presence of an
ICD-10-AM code for RA (M05xx; M060x; M062x; M063x;
M068x; M069x) during the joint surgery admission or
during any hospital admission in the 2-year retrospective
period.
Outcomes
MI was defined by the ICD-10-AM diagnostic code I21xx,
and occurrence of MI within 6 weeks and 12 months of
joint surgery was generated from the index joint surgery
admission and hospital admissions that occurred in the
12 months following the index admission. Death within
6 weeks and 12 months of joint surgery was generated
from the death registry component of the dataset. Cause
of death data were provided in text format, and a text
string-searching algorithm was used to search cause of
death data for cardiovascular deaths. For the purposes of
this study, cardiovascular death included the following
causes: MI, angina pectoris, ischemic heart disease, con-
gestive heart failure, cardiomyopathy, arrhythmia, pulmon-
ary edema, stroke, thromboembolism and cardiac arrest.
Other covariates
Individual comorbidities from the ICD-10-AM version
of the Charlson Comorbidity Index [13] and additional
comorbidities of clinical significance (hypertension, smok-
ing and dyslipidemia) were defined using ICD-10-AM
diagnostic codes recorded at the time of joint surgery
(Additional file 1). Socioeconomic status was estimated
using the Index of Relative Socioeconomic Disadvantage
(IRSD) of the Socio-Economic Indexes for Areas (SEIFA)
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based on place of residence (statistical local area), from
the Australian Bureau of Statistics 2006 Census data [14].
The IRSD is derived from the Census variables related to
disadvantage, such as low income, low educational at-
tainment, unemployment, and dwellings without motor
vehicles. A dichotomous variable was generated from the
IRSD, reflecting statistical local areas in the lowest quartile
in comparison to the areas in the top three quartiles.
The Accessibility/Remoteness Index of Australia (ARIA)
from the Australian Department of Health and Aged Care
was used to provide an indication of availability of goods
and services, including health services, in an individual’s
statistical local area [15]. The ARIA methodology uses
Geographical Information System capabilities to produce
a continuous variable with values between 0 and 12, where
0 indicates areas of highest accessibility and 12 indicates
areas of highest remoteness. Those areas classified as
highly accessible have no restrictions on their access to
most goods and services. In Victoria, which has fewer
remote regions compared to other parts of Australia,
the ARIA score corresponds to three levels of accessi-
bility: highly accessible (ARIA score 0–1.84), accessible
(ARIA score >1.84–3.51) or moderately accessible (ARIA
score >3.51–5.80). For this study, a dichotomous variable
was generated from the ARIA comparing those living in
highly accessible areas to those living in accessible or
moderately accessible areas.
Patients who are admitted to a Victorian hospital are
classified as either public, private, Department of Vet-
erans Affairs (DVA) or compensable (work-related injury
or transport accident) based on the funding source for
the hospital admission. In Australia, all eligible residents
have access to medical care through Medicare, the pub-
licly funded universal health care scheme [16]. Medicare
covers in-hospital inpatient and outpatient treatment at
no cost to the patient, and subsidized community med-
ical care, investigations and pharmaceuticals. Australians
can chose to have Medicare cover only, or a combin-
ation of Medicare (public) and private health insurance.
Medicare does not cover private patient hospital costs. A
dichotomous variable was generated to compare public
patients to all other patient types.
Statistical methods
The statistical analysis consisted of initial descriptive and
exploratory bivariate analysis, comparing demographic
characteristics and clinical features of those with RA to
those without. All categorical data were assessed using
the Chi-square test, and the Mann–Whitney test was used
to assess the difference in age between the two groups.
Multivariate logistic regression analyses were conducted
to assess the impact of RA on MI and mortality outcomes
after adjusting for relevant covariates. Four logistic re-
gression models were fitted with RA status as the key
exposure variable and outcomes, including 6-week and
12-month postoperative MI, all-cause mortality and cardio-
vascular mortality, respectively. Covariate adjustments in-
cluded age, sex, comorbidities, socioeconomic status and
type of joint surgery (hip and knee arthroplasty vs all other
types of surgery), and variables with a p value <0.2 in the bi-
variate analysis were included [17]. Robust standard errors
were used to allow for clustering by patient, as some patients
had multiple episodes during the study period [18]. Statistical
significance was set at p <0.05. All analyses were conducted
using Stata/SE 12.1 software (StataCorp LP, TX, USA). This
study was approved by the Melbourne Health Human
Research Ethics Committee (HREC number 2010.104).
Results
During the study period 240,571 individuals underwent
a total of 308,589 joint surgery procedures, of which
3,654 (1.2 %) were performed on 2,219 people (0.92 %)
with RA. Among the RA group, hip and knee joint
arthroplasty were the most commonly performed surgi-
cal procedures (55.5 %), whereas in the non-RA group
these types of surgery accounted for 26.6 % of all proce-
dures. See Additional file 2 for further details of type of
joint surgery episodes by RA status. The demographic
details and clinical features of the RA and non-RA groups
are shown in Table 1. Compared to those without RA, the
patients with RA were older and more likely to be female,
of lower socioeconomic status, less likely to be smokers
and had a greater burden of comorbid disease, including
hypertension, diabetes, vascular disease, pulmonary disease
and renal disease. There were fewer elective and more pub-
lic patient admissions among people with RA compared to
those without RA, but there were no differences between
the groups in accessibility to goods and services, or the num-
bers with an English-speaking background. See Additional
file 3 for summary of patient level data.
Table 2 shows the number of events and odds ratios
(OR) of MI and mortality following joint surgery in the
RA and non-RA groups. Unadjusted models showed those
with RA had greater odds of experiencing MI or death
at both 6 weeks and 12 months compared to the non-RA
group. After adjusting for age, sex, comorbidities and
other potential confounders the OR for MI within 6 weeks
of joint surgery in the RA patient group remained elevated
but was no longer statistically significant (OR 1.50,
95 % CI 0.96–2.33) (Table 2). The adjusted OR for all
other 6-week and 12-month outcomes remained statisti-
cally higher in the RA group as follows: all-cause death
within 6 weeks (adjusted OR 1.85, 95 % CI 1.09–3.13) and
12 months (adjusted OR 2.18, 95 % CI 1.66–2.86), cardio-
vascular death within 6 weeks (adjusted OR 1.90, 95 % CI
1.07–3.37) and 12 months (adjusted OR 2.30, 95 % CI
1.65–3.22) and MI within 12 months (adjusted OR 1.70,
95 % CI 1.27–2.28).
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The results from the subgroup analysis are given in
Table 3. Among the THJR group, the adjusted OR for
CV death within 6 weeks and 12 months, and all-cause
death within 12 months were significantly higher for
those with RA. Following TKJR surgery, the adjusted OR
for MI and death at 6 weeks and 12 months were no dif-
ferent between the groups. Following all other types of
joint surgery, the adjusted OR for MI at 6 weeks and all
12-month outcomes was significantly higher for those
with RA. However, the adjusted OR for death within
6 weeks was no different between the RA and non-RA
group.
Discussion
This large population-based study investigated the 6-week
and 12-month risk of MI and mortality among RA
Table 1 Summary of joint surgery admissions among patients with and without rheumatoid arthritis (RA)
RA Non-RA p value
Joint surgery admissions, n (%) 3654 (1.2) 304,935 (98.8)
Female, n (%) 2727 (74.6) 139,184 (45.6) <0.0001
Age, median years (interquartile range) 64 (54–72) 54 (39–67) <0.0001
Comorbidities during joint surgery admission, n (%)
Smoker 386 (10.6) 40,958 (13.4) <0.0001
Hypertension 308 (8.4) 16,269 (5.3) <0.0001
dyslipidaemia 39 (1.1) 2612 (0.86) 0.170
Diabetes mellitus 218 (6.0) 12,682 (4.2) <0.0001
Peripheral vascular disease 16 (0.44) 410 (0.13) <0.0001
Pulmonary disease 74 (2.0) 1892 (0.62) <0.0001
Peptic ulcer disease 12 (0.33) 269 (0.09) <0.0001
Renal disease 56 (1.5) 1744 (0.57) <0.0001
Liver disease 2 (0.05) 104 (0.03) 0.504
Cerebrovascular accident 21 (0.57) 787 (0.26) <0.0001
Congestive heart failure 56 (1.5) 1673 (0.55) <0.0001
Cancer or metastatic cancer 15 (0.14) 844 (0.28) 0.127
Paraplegia 16 (0.44) 466 (0.15) <0.0001
Dementia 6 (0.16) 333 (0.11) 0.318
Human immunodeficiency disease 0 40 (0.01) 0.489
Lowest quartile of socioeconomic statusa, n (%) 446 (12.2) 32,312 (10.6) 0.002
High accessibility to goods and servicesb, n (%) 3214 (88.0) 269,242 (88.3) 0.301
Public hospital patient, n (%) 1343 (36.8) 76,246 (25.0) <0.0001
Elective admission, n (%) 3428 (93.8) 294,892 (96.7) <0.0001
English-speaking country of birth, n (%) 3119 (85.4) 259,100 (85.0) 0.512
Hip and knee total, partial or revision arthroplasty, n (%) 2028 (55.5) 81,094 (26.6) <0.0001
aIndex of Relative Socioeconomic Disadvantage from the Australian Bureau of Statistics 2006 Census data; bAccessibility Remoteness Index of Australia
Table 2 Myocardial infarction and mortality following joint surgery in patients with and without rheumatoid arthritis
Outcome RA (n = 3654) Non-RA (n = 304,935) Unadjusted ORa (95 % CI) Adjusted ORab (95 % CI)
MI within 6 weeks 25 (0.68) 838 (0.27) 2.50 (1.68–3.73) 1.50 (0.96–2.33)
MI within 12 months 59 (1.61) 1968 (0.65) 2.53 (1.95–3.28) 1.70 (1.27–2.28)
All-cause death within 6 weeks 22 (0.60) 569 (0.19) 3.24 (2.11–4.97) 1.85 (1.09–3.13)
All-cause death within 12 months 93 (2.55) 2411 (0.79) 3.28 (2.66–4.04) 2.18 (1.66–2.86)
CV death within 6 weeks 15 (0.41) 372 (0.12) 3.37 (2.01–5.66) 1.90 (1.07–3.37)
CV death within 12 months 61 (1.67) 1406 (0.46) 3.67 (2.83–4.75) 2.30 (1.65–3.22)
Values for RA and Non-RA are the number (%) of episodes. aReference group patients without rheumatoid arthritis; badjusted for age, sex, comorbidities, admission
type (emergency vs elective), patient type (public vs private), socioeconomic status and joint surgery type (hip, knee, ankle and shoulder joint arthroplasty/arthrodesis vs
all other). MI myocardial infarction, CV cardiovascular, RA rheumatoid arthritis, O, odds ratio; CI confidence interval. Results in italics are statistically significant
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patients undergoing any form of joint surgery, with
subgroup analysis of total hip and knee arthroplasty.
Patients with RA had adjusted odds of cardiovascular
and all-cause mortality at 6 weeks after surgery that
were nearly twice those of patients without RA. In our
subgroup analysis, patients with RA had significantly
higher odds of MI within 6 weeks and 12 months fol-
lowing joint surgery other than TKJR and THJR. An
increased risk of early cardiovascular mortality was
also demonstrated when analysis was limited to THJR
surgery but not in patients with RA who underwent
TKJR or other types of joint surgery. Outcomes at
12 months were almost universally worse for patients
with RA, with cardiovascular and all-cause mortality
significantly elevated in the cohort overall, and in the
subgroup analysis among those who had undergone
THJR surgery and joint surgery other than hip and
knee arthroplasty. MI within 12 months of surgery was in-
creased in the RA group overall, and was elevated but not
statistically significantly so for the patients with RA who
underwent total hip or knee joint arthroplasty.
Our findings of an increased risk of short-term death
in the overall joint surgery cohort are consistent with a
previous study. Soohoo et al. reviewed data from 138,399
patients undergoing primary THJR in California from 1995
to 2005, and as in our study, found that patients with RA
had a significantly increased risk of short-term (90-day)
mortality compared to patients with osteoarthritis (OR
1.88, 95 % CI 1.17–3.03) [19]. However, in most studies, as
with the findings from our subgroup analysis of TKJR
and THJR surgery, there was no difference in all-cause
short-term mortality following hip and knee arthroplasty
[7–9, 20–23]. A meta-analysis by Ravi et al. reported no
evidence of excess 90-day mortality in patients with RA
following THJR (OR 1.40, 95 % CI 0.82–2.39), or TKJR
(OR 0.86, 95 % CI = 0.66–1.12) [21]. Subsequent to the
meta-analysis, a number of studies have examined compli-
cations, including cardiovascular events and mortality, in
patients with RA, following total joint arthroplasty. All
studies reported no difference in the odds of short-term
mortality [7, 8, 22, 23].
Very few studies have investigated long-term risk of
mortality. We found a significant difference in the odds
of 12-month mortality between the RA and non-RA
groups in the total cohort or in the THJR subgroup ana-
lysis. Michaud et al. analyzed 7 years of data from US
veterans to examine the complications and mortality in
RA patients following total hip or knee arthroplasty [22].
Unlike our findings, there was no difference identified in
mortality at 12 months (OR 1.30, 95 % CI 0.87–1.96) in
the 839 patients with RA compared to those with osteo-
arthritis. However in their analysis of mortality up to
8 years post-surgery they reported an increased risk
among those with RA compared to those with osteoarth-
ritis (hazard ratio 1.22, 95 % CI 1.00–1.49).
Short-term risk of cardiovascular complications other
than death has been assessed in a number of studies. In
our total cohort of patients who underwent joint surgery
and among those who underwent THJR and TKJR we
found there was no difference in short-term risk of MI
between the RA and non-RA groups. Similarly, in patients
with RA compared to those with osteoarthritis, Michaud
et al. did not observe any difference in the odds of car-
diovascular events (including MI and cerebrovascular
accident) within 30 days. In another study of 351,103
TKJR episodes between 2006 and 2010, of which 11,755
patients had RA, Stundner and colleagues also did not
find any difference in the odds for combined perioperative
adverse events (which included 30-day mortality, MI, in-
fections and other complications) in patients with RA
compared to those with osteoarthritis (adjusted OR 0.98,
95 % CI 0.92–1.05) [7]. In contrast, Stundner et al. ex-
amined US data from 157,775 THJR episodes between
2006 and 2010, of which 5,400 were in patients with
RA, and found that patients with RA had higher overall
odds of perioperative complications, including cardio-
vascular complications (adjusted OR 1.15, 95 % CI
1.05–1.25), compared to people with osteoarthritis [8].
Table 3 Adjusted odds ratios for myocardial infarction and mortality following THJR, TKJR and all other joint surgery in patients with
and without rheumatoid arthritis
Outcome THJR: 35,179 episodes TKJR: 32,787 episodes All other joint surgery: 240,633 episodes
Adjusted ORa (95 % CI) Adjusted ORa (95 % CI) Adjusted ORa (95 % CI)
MI within 6 weeks 1.31 (0.56–3.05) 0.84 (0.33–2.14) 2.32 (1.24–4.34)
MI within 12 months 1.56 (0.87–2.79) 1.22 (0.71–2.11) 2.20 (1.47–3.30)
All-cause death within 6 weeks 2.13 (0.93–4.90) 1.38 (0.27–7.04) 1.84 (0.90–3.76)
All-cause death within 12 months 1.79 (1.07–2.99) 1.57 (0.79–3.13) 2.72 (1.92–3.84)
CV death within 6 weeks 2.58 (1.02–6.52) 0.89 (0.12–6.68) 1.93 (0.85–4.36)
CV death within 12 months 1.99 (1.09–3.60) 1.86 (0.87–4.00) 2.70 (1.76–4.15)
aReference group patients without rheumatoid arthritis. THJR total hip joint replacement, TKJR total knee joint replacement, MI myocardial infarction, CV cardiovascular,
RA rheumatoid arthritis, OR odds ratio, CI confidence interval. Adjusted for age, sex, comorbidities, socioeconomic status, patient type and admission type
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Among those who underwent surgery other than THJR
and TKJR, we found people with RA had an increased risk
of MI within 6 weeks. This group of patients were mainly
undergoing knee arthroscopy (69 %) and surgery on the
shoulder (16 %) with the remainder undergoing hand/
wrist, elbow and ankle surgery (8 %) and a small number
undergoing revision arthroplasty of the hip or knee (6 %).
This increased risk of MI within a group predominantly
undergoing a presumably less significant hemodynamic
insult is of interest and suggests the possibility that even
relatively minor physiologic stress could precipitate a car-
diovascular event in a predisposed patient with RA. Our
data do not specifically address this issue, however.
The differences in findings from our study compared
to other studies may be explained by a number of factors,
including the differences in study time periods examined,
the prevalence of RA, the variation in the postoperative
time period examined (for example 6 weeks versus 90 days),
combination of cardiovascular complications into one
measure in a number of studies (whereas we looked at
MI on its own) and differences in demographic character-
istics of the study population. In particular, the Michaud
study was a predominantly male population compared to
our study, which involved predominantly female patients
with RA.
Our study adds to the findings of the above mentioned
studies by reporting on outcomes for patients with RA
following joint surgery other than hip and knee arthro-
plasty. We found that joint surgery was not related to
short-term MI but was significantly associated with
short-term mortality and long-term MI and mortality.
It is unknown whether this finding is related to the overall
increased risk of CV events and mortality among patients
with RA [24]. Further research should consider an investi-
gation of CV outcomes and mortality in patients with RA
undergoing surgery and those not receiving surgery, to de-
termine if there is an additive risk associated with surgery.
This study utilized 10 years of hospital administrative
data for all types of joint surgery within a single Australian
state and included outcome information for 308,589 pro-
cedures, including 3,654 involving patients with RA. There
are, however, several limitations that should be noted. The
classification of patients with RA was based on coded
diagnosis of RA in the hospital record, which was not col-
lected specifically for research purposes. We utilized a
2 year retrospective period to increase the chances of ac-
curately detecting RA cases, however, mild cases of RA
may have been missed. The use of hospital administrative
data to ascertain RA status may result in misclassification.
We may have misclassified people with mild RA as false
negatives (that is, no diagnosis of RA), and only captured
patients with more severe or active RA who had been hos-
pitalized. However, this is likely to lead to a bias toward
the null hypothesis and is therefore a more conservative
estimation of the true effect. We did not have access to
medication data or outpatient administrative data to fur-
ther validate the RA diagnosis. However, findings from an
Australian study into the quality of ICD-10 coding of Vic-
torian hospital discharge data reported the sensitivity and
positive predictive value (PPV) for identifying RA as 91 %
(95 % CI 74–100 %) and 77 % (95 % CI 54–100 %), re-
spectively [25]. In addition, a recent Canadian validation
study reported the optimal algorithm for identifying pa-
tients with RA from health administrative data was one
hospitalization code ever or three physician diagnosis
codes from claims with one or more RA code by a special-
ist in a 2-year period [26]. The comparability of Canadian
and Australian coded administrative hospital data for iden-
tifying RA is unknown. Our classification of comorbidities
was also dependent on coded data, which may have inac-
curacies but is unlikely to be differentially distributed
between RA and non-RA cases, and therefore unlikely
to introduce systematic bias into the results [27].
We were interested in assessing all-cause mortality as
well as cardiovascular mortality. The cause of death data
were available in text form only and did not allow us to
use a more standardized approach (for example, using
ICD-10 codes) to define cardiovascular death, or differ-
entiate between an underlying and associated cause of
death. We accept this is a limitation of the study as it
may result in misclassification of this outcome. However,
this is unlikely to be unequally distributed between the
RA and non-RA group and again unlikely to introduce
systematic bias into the results.
Information on RA severity, activity, treatment, prevent-
ive care and use of cardiovascular medicines was not avail-
able, and we therefore unable to examine the influence of
these factors on postoperative mortality. Our dataset does
not capture non-fatal events that occur outside the Victor-
ian hospital setting, such as those that occur in the commu-
nity and do not result in hospitalization or hospitalization
in other Australian states. Consequently we may have
underestimated the true burden of postoperative MI in our
cohort. Finally, with the growing use of biological disease-
modifying anti-rheumatic drugs, the incidence of joint sur-
gery has been decreasing and long-term prognosis has been
improving for people with RA [28, 29]. As such, the odds
of mortality and morbidity presented in this study may
differ from current measures of risk, as the profile of
people with RA receiving joint surgery is evolving over
time.
Conclusion
In conclusion, at 6 weeks following joint surgery, pa-
tients with RA had almost double the odds of all-cause
and CV mortality compared to those without RA. At
12 months post joint surgery, the RA group had signifi-
cantly higher odds of MI, all-cause death and CV death
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compared to those without RA. Understanding the risks
of postoperative MI and mortality can help patients with
RA make informed decisions about undergoing joint sur-
gery procedures. Further studies to determine the contri-
bution of subclinical cardiovascular disease, RA disease
severity, functional status and RA treatments to this in-
creased mortality are warranted.
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